All Stories: Novartis

Novartis said its anti-inflammatory drug Cosentyx eased the symptoms of a painful, lump-forming skin condition in two late-stage trials, putting the approved treatment on...

GSK and Novartis on Thursday reinforced commitments to address neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways...

Novartis’s Sandoz division will not make a profit on 15 generic drugs it is making available to developing countries to treat symptoms of COVID-19

Hydroxychloroquine, is not included after some COVID-19 trials concluded it did not work

A charity will pay $4 million to resolve claims that it acted as a conduit for companies including Biogen and Novartis to pay kickbacks to patients using their high-priced multiple sclerosis drugs

The US Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized a decision to cover expensive cancer cell therapies

Novartis AG says investigation is underway into whether a second trial death could be related to the treatment

ZURICH/NEW YORK: Novartis and Pfizer are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative...

ZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection risks and...

WASHINGTON/LOS ANGELES: U.S. President Donald Trump on Tuesday met with top executives from some of the biggest drugmakers, calling on them to boost U.S. production...

BASEL, Switzerland: An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and...

NEW YORK: Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it...

PARIS: The first new asthma pill in nearly 20 years has led to a sharp improvement in symptoms for chronic sufferers of the disease, according to an early test of the drug.

WASHINGTON: U.S. regulators have declined to approve Novartis' so-called biosimilar copy of Amgen's Neulasta drug that fights infections in cancer patients, the Swiss drugmaker said on Tuesday.

CHICAGO: A Novartis trial of two drugs against an aggressive lung cancer bodes well for broadening their use beyond melanoma, the Swiss drugmaker told the American Society of Clinical Oncology's conference in Chicago on Tuesday. Novartis's Tafinlar and Mekinist combination shrank tumors in 63 percent of the trial's 57 people with BRAF V600E-mutation positive non-small cell lung cancer who had failed on chemotherapy, the company said, citing a Phase II study.

LONDON: Efforts by Novartis to defend its blockbuster cancer drug Afinitor against competitors got a boost on Thursday from European regulators, who approved it for use on certain types of advanced gastrointestinal and lung neuroendocrine tumors.

The Ankara Chief Prosecutor has launched an investigation into the Turkish unit of Swiss drugmaker Novartis, local media reported on Friday, after allegations it benefited from bribery.

The U.S. Food and Drug Administration approved Novartis AG's injectable drug, Cosentyx, to treat adults with a moderate to severe skin disease called plaque psoriasis.

The device for diabetics would measure glucose in tear fluid and send the data wirelessly to a mobile device, Novartis said. The technology is...